Key facts
- This page summarizes Thomas Englese's Form 3 filing for Tonix Pharmaceuticals Holding Corp. (TNXP).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 08 Sep 2026, 07:05.
Thomas Englese - 04 Sep 2026 Form 3 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- TNXP
- Reported as of
- 04 Sep 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 08 Sep 2026, 07:05:30 UTC
- Prior SEC filing
- 09 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas Englese
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Thomas Englese filed Form 3 for Tonix Pharmaceuticals Holding Corp. (TNXP) on 08 Sep 2026.
Change
- Previous filing in this sequence was filed on 09 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001825799
Primary reporting owner
Englese Thomas
- Relationship
- Chief Commercial Officer
- Address
- C/O TONIX PHARMACEUTICALS HOLDING CORP, 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS
- Signature
- /s/ Thomas Englese
- Signature date
- 08 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TNXP
holding
Common Stock, $0.001 par value per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 694
- Date
- 04 Sep 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TNXP
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 500
- Exercise price
- $16.51
- Footnotes
- F1
TNXP
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,500
- Exercise price
- $8.05
- Footnotes
- F2
TNXP
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,480
- Exercise price
- $20.18
- Footnotes
- F3
TNXP
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 04 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $14.29
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The option was granted on September 9, 2024, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
Footnote F2
The option was granted on February 25, 2025, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
Footnote F3
The option was granted on May 13, 2025, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/4th on the first anniversary of issuance and 1/48th each month thereafter for 36 months.
Footnote F4
The option was granted on February 24, 2026, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/4th on the first anniversary of issuance and 1/48th each month thereafter for 36 months.